Efficacy and Safety of Grazoprevir (+) Uprifosbuvir (+) Ruzasvir (MK-3682B) (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Clinical trial NCT02613403 · TERMINATED
Trial details
- NCT number
- NCT02613403
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-10
- Primary completion
- 2017-01-09
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.